Background {#Sec1}
==========

Globally, breast cancer is the most common malignancy and the leading cause of cancer-related deaths among women \[[@CR1], [@CR2]\]. In the United States, one in eight women will develop breast cancer during their lifetime \[[@CR3]\]. Management of breast cancer includes surgery followed by radiotherapy (RT). Other treatment approaches include chemotherapy, endocrine therapy, and molecular targeted therapy \[[@CR4]\]. Breast cancer remission in most cases is accompanied by concomitant short and/or long term damage to the physiological structure and function \[[@CR5]--[@CR10]\]. This could ultimately limit the patients' activities of daily living and represent a source of long term impairment \[[@CR8]--[@CR14]\].

Advances in early diagnosis and treatment of breast cancer have helped improve patient survival. Consequently, the number of people living with disease sequelae is projected to increase over time. Providing long-term health care to these patients and measuring the impact of these services are pragmatic approaches. Assessment of cancer-specific quality of life (QOL) is an ideal approach towards this end. The European Organization Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire is a widely used instrument to assess the QOL of cancer patients \[[@CR15]\]. Its specific module on breast cancer is the EORTC QLQ-BR23 \[[@CR16]\]. Several studies have focused on the association between various treatment modalities (such as, surgical approach, radiation and chemotherapy regime or endocrine therapy) and QOL of patients with breast cancer \[[@CR17]\]. However, few studies have investigated the temporal changes in QOL of these patients after completion of radiotherapy.

In the present study, we assessed the QOL of breast cancer patients at different time intervals after completion of RT using EORTC QLQ-C30 and EORTC QLQ-BR23 questionnaires. The objective was to assess whether time elapsed since completion of RT has a bearing on the QOL of these patients.

Methods {#Sec2}
=======

Study design {#Sec3}
------------

Patients with breast cancer were recruited at the Department of Radiation Oncology at the First Affiliated Hospital of Anhui Medical University, from January 2013 to April 2016. Breast cancer patients who received RT post surgery were enrolled in the study. Written informed consent was obtained from all patients prior to their enrolment. The study was approved by the ethics committee of The First Affiliated Hospital of Anhui Medical University.

Implementation of questionnaire survey {#Sec4}
--------------------------------------

Patients were divided into four groups based on time elapsed since completion of radiotherapy (0--1.5 years; 1.5--2.5 years; 2.5--3.5 years; and 3.5--4.5 years). Patients were administered both EORTC QLQ-C30 and QLQ-BR23 questionnaires. QLQ-C30 is a generic questionnaire used to assess patients with various tumors, while QLQ-BR23 is a breast cancer-specific questionnaire.

Statistical analysis {#Sec5}
--------------------

Epidata 3.0 was used for data entry. Data are presented as mean ± standard deviation (SD) or as frequencies (percentages). ANOVA test was used to compare the QOL at different time intervals post RT. Multiple regression model was used to conduct multivariate analysis. Variables included in the model were age, educational level, surgical technique, surgical staging, number of chemotherapy cycles, and time elapsed since completion of RT. All statistical analyses were performed using SSPS 13.0 (SAS Institute, Inc., Cary, North Carolina); *p* values \< 0.05 were considered statistically significant.

Results {#Sec6}
=======

Patient characteristics {#Sec7}
-----------------------

A total of 300 patients who had undergone surgery for breast cancer were enrolled in the study; Patients were followed up in March 2017. The valid number of patients is 212 (80 patients were lost to follow-up and eight patients died). The median follow-up time was 27.2 months. The number of patients followed up for 0 to 1.5 years, 1.5 to 2.5 years, 2.5 to 3.5 years and 3.5 to 4.5 years were 64, 61, 66 and 21, respectively. Patient characteristics are listed in Table [1](#Tab1){ref-type="table"}. The mean (±SD) age of patients was 48.36 ± 8.95 years. About 11.3% of patients were illiterate; 28.8% were educated up to primary school level, 43.9% were educated up to middle school and 16.0% of patients were educated up to college level or above. More than 95.3% of patients were married. Most patients had stage II (53.3%) or III (37.3%) disease. Percentages of patients who had received breast-conserving surgery, breast reconstruction surgery and modified radical mastectomy were 22.2%, 5.2% and 72.6%, respectively (Table [1](#Tab1){ref-type="table"}).Table 1Patients' characteristicsVariablesMean ± SD or n (%)Age (years)48.36 ± 8.95Level of educationIlliterate24 (11.3)Primary School61 (28.8)Middle School93 (43.9)College or above34 (16.0)Marital statusUnmarried10 (4.7)Married202 (95.3)Clinical stage02 (0.9)I11 (5.2)II113 (53.3)III79 (37.3)IV7 (3.3)Surgical techniqueBreast-conserving surgery47 (22.2)Breast reconstruction surgery11 (5.2)Modified radical mastectomy154 (72.6)

Univariate analysis of EORTC QLQ-C30 data {#Sec8}
-----------------------------------------

Of the 15 subscales, only the role function, social function, pain and financial impact of disease scores exhibited significant changes over time after radiotherapy (*p* \< 0.002). Of these, the role function score showed the highest level in the 2.5 to 3.5 years time window post-radiotherapy. Pain scores in the 2.5 to 4.5 years time window post- radiotherapy were significantly lower than those in the 0 to 2.5 years time window, which indicates subsidence of pain over time. The scores for financial impact of disease showed fluctuations over time (45.83 ± 33.60, 42.86 ± 36.67, 18.10 ± 29.53 and 53.33 ± 50.18 in the 0--1.5; 1.5--2.5; 2.5--3.5; and 3.5--4.5 years groups, respectively). The economic impact was found to be lower during the time window of 2.5 to 3.5 years since completion of RT. The total QOL score did not change significantly in different time intervals post RT with respect to the other subscales of function and clinical symptoms (Table [2](#Tab2){ref-type="table"}).Table 2Results of univariate analysis of EORTC QLQ-C30 questionnaire dataScaleTime elapsed since completion of radiotherapy*F*-value*p*-value Functional scales0--1.5 years1.5--2.5 years2.5--3.5 years3.5--4.5 years Physical function72.50 ± 28.1771.43 ± 22.2781.71 ± 24.9190.00 ± 25.381.6430.184 Role function88.28 ± 17.9482.86 ± 25.5695.71 ± 9.5685.00 ± 24.152.7150.048 Emotional function89.38 ± 21.5490.00 ± 13.9384.00 ± 20.7581.00 ± 21.831.0540.372 Cognitive function76.56 ± 22.8480.00 ± 17.9971.43 ± 30.4077.50 ± 14.190.7880.503 Social function80.73 ± 25.7979.52 ± 16.7193.33 ± 16.2791.67 ± 11.794.0140.009Symptom scales Tiredness26.82 ± 29.8323.38 ± 28.4320.53 ± 27.593.99 ± 12.621.8010.151 Nausea/vomiting2.08 ± 7.023.81 ± 17.663.33 ± 9.740.00 ± 0.000.3290.804 Pain35.42 ± 31.6137.14 ± 33.1118.10 ± 29.5316.67 ± 23.573.2610.024 Shortness of breath9.38 ± 29.615.71 ± 23.5511.43 ± 32.2810.00 ± 31.620.2380.870 Sleep disturbance9.38 ± 17.426.67 ± 17.7114.29 ± 23.2710.00 ± 31.620.7900.502 Lack of appetite9.38 ± 29.618.57 ± 28.408.57 ± 28.4010.00 ± 31.620.0110.998 Constipation7.29 ± 18.423.81 ± 10.766.67 ± 13.5320.00 ± 42.162.0130.116 Diarrhea3.13 ± 17.681.43 ± 8.451.43 ± 8.450.00 ± 0.000.2430.866 Financial impact of disease45.83 ± 33.6042.86 ± 36.6718.10 ± 29.5353.33 ± 50.185.1070.002 Overall state of health76.82 ± 14.1676.67 ± 14.1268.10 ± 24.6376.67 ± 10.101.8630.140

Univariate analysis of EORTC QLQ-BR23 data {#Sec9}
------------------------------------------

Statistically significant between-group differences were observed with respect to scores for perception of own body, sexual activity, enjoyment of sexual activity, concerns about future state of health and symptoms in the breast (*P* \< 0.05). The scores for perception of own body increased during the 0 to 3.5 years time window after RT, and then decreased during the 3.5 to 4.5 years time window. Similar trend was observed with respect to the subscales of sexual activity and enjoyment of sexual activity in that the scores dropped significantly during the 2.5 to 4.5 year time window as compared to those during the 0 to 2.5 year time window after completion of RT. On the contrary, the scores for concerns about future state of health rose significantly during the 2.5 to 4.5 year time window as compared with that during the 0 to 2.5 year time window after completion of RT. The scores for subscale of symptoms in the breast fluctuated; the highest scores pertained to the 0 to 1.5 year time window after completion of RT (Table [3](#Tab3){ref-type="table"}).Table 3Results of univariate analysis of EORTC QLQ-BR23 questionnaire dataScaleTime elapsed since completion of radiotherapy*F*-value*p*-value Functional scales0--1.5 years1.5--2.5 years2.5--3.5 years3.5--4.5 years Perception of own body82.29 ± 25.0290.24 ± 14.5094.52 ± 11.0688.33 ± 15.812.8000.043Sexual activity81.77 ± 26.2289.52 ± 22.1771.90 ± 27.0576.67 ± 35.312.7350.047 Enjoyment of sexual activity83.33 ± 26.7691.43 ± 20.3671.43 ± 28.1776.67 ± 35.313.5460.017 Concerns about future state of health71.88 ± 33.4574.29 ± 30.6192.86 ± 17.7585.00 ± 24.154.0480.009Symptom scales Side-effects of therapy23.44 ± 23.5230.00 ± 28.8121.42 ± 24.1138.33 ± 23.641.5490.206 Symptoms in the breast32.81 ± 32.0317.86 ± 20.6317.14 ± 22.5025.00 ± 16.672.8510.041 Symptoms in arm/shoulder15.66 ± 20.4413.84 ± 18.009.31 ± 9.8820.05 ± 14.311.4800.224 Low mood because of hair loss1.56 ± 8.844.29 ± 18.674.29 ± 14.2010.00 ± 21.080.7960.499

Results of multivariate linear regression analysis {#Sec10}
--------------------------------------------------

On multivariate analysis, time elapsed since completion of RT was an independent predictor of social function, pain, and concerns about future state of health (*p* = 0.003, *p* = 0.011, and *p* = 0.013, respectively) (Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}).Table 4Variables showing no significant association with time elapsed since radiotherapy on multivariate analysesVariablesRegression coefficientsStandard errorStandard regression coefficient*tp*-valueRole function Constant term75.36618.565 Age0.4730.2150.2142.2000.030 Level of education2.6092.2320.1211.1690.245 Surgical technique−0.2202.450−0.009− 0.0900.929 Surgical staging−5.8073.145−0.189−1.8460.068 Number of chemotherapy cycles−0.1370.976− 0.014− 0.1410.888 Time elapsed since completion of RT2.2311.9770.1081.1290.262Financial impact of disease Constant term76.84331.830 Age0.3920.3690.0951.0620.291 Degree of education−14.8593.827−0.370−3.8830.000 Surgical technique7.7934.2010.1741.8550.066 Surgical staging−13.6315.393−0.237−2.5280.013 Number of chemotherapy cycles2.6381.6730.1391.5760.118 Time elapsed since completion of RT−3.2023.390−0.083−0.9440.347Perception of own body Constant term32.59516.150 Age0.4290.1870.2152.2920.024 Level of education6.4071.9420.3293.3000.001 Surgical technique−0.0842.131−0.004−0.0390.969 Surgical staging4.2792.7360.1541.5640.121 Number of chemotherapy cycles−0.5630.849−0.061− 0.6630.508 Time elapsed since \`completion of RT3.2191.7200.1731.8710.064 Sexual activity Constant term60.28823.972 Age0.8100.2780.2702.9160.004 Level of education−4.5352.882−0.156−1.5740.119 Surgical technique−0.9263.164−0.029− 0.2930.770 Surgical staging3.9434.0610.0950.9710.334Number of chemotherapy cycles−1.5961.260−0.116−1.2670.208 Time elapsed since completion of RT−3.5472.553−0.127−1.3890.168Enjoyment of sexual activity Constant term55.92823.971 Age0.8300.2780.2742.9890.003 Level of education−4.3522.882−0.147−1.5100.134 Surgical technique−0.1053.164−0.003− 0.0330.974 Surgical staging5.1844.0610.1231.2770.205 Number of chemotherapy cycles−1.6771.260−0.120−1.3300.186 Time elapsed since completion of RT−4.5242.553−0.160−1.7720.079Symptoms in the breast Constant term42.09024.453 Age−0.0800.283−0.028− 0.2820.778 Level of education−1.2132.940−0.044−0.4130.681 Surgical technique−2.5573.227−0.083−0.7920.430 Surgical staging0.9344.1430.0240.2250.822 Number of chemotherapy cycles0.0971.2850.0070.0760.940 Time elapsed since completion of RT−4.4102.604−0.167−1.6930.093Table 5Variables showing a significant association with time elapsed since radiotherapy on multivariate analysesVariablesRegression coefficientsStandard errorStandard regression coefficientt-value*p*-valueSocial function Constant term70.10417.984 Age−0.1610.208−0.071−0.7700.443 Level of education2.5002.1620.1141.1560.250 Surgical technique−5.5852.373−0.230−2.3530.020 Surgical staging1.7873.0470.0570.5860.559 Number of chemotherapy cycles1.8040.9450.1751.9080.059 Time elapsed since completion of RT5.7871.9150.2763.0220.003Pain Constant term−0.57829.509 Age0.6640.3420.1871.9410.055 Level of education6.0303.5480.1751.7000.092 Surgical technique−1.4813.894−0.038−0.3800.704 Surgical staging0.9195.0000.0190.1840.854 Number of chemotherapy cycles−0.1061.551−0.006− 0.0680.946 Time elapsed since completion of RT−8.1183.143−0.245−2.5830.011Concerns about future state of health Constant term−0.28025.906 Age0.2370.3000.0740.7880.432 Level of education6.0923.1150.1951.9560.053 Surgical technique−3.3033.419−0.095−0.9660.336 Surgical staging13.2894.3890.2973.0280.003 Number of chemotherapy cycles−0.1311.362−0.009− 0.0960.923 Time elapsed since completion of RT6.9742.7590.2332.5280.013

Discussion {#Sec11}
==========

The present study is among the few studies which have evaluated the effect of time elapsed since completion of radiotherapy on the QOL of breast cancer patients following breast surgery using the EORTC QLQ-C30 and EORTC QLQ-BR23 instruments. We found that the patients' social function, as measured with the EORTC QLQ-C30, improved significantly with passage of time during the 2.5 to 4.5 year time window after completion of RT. Social function refers to the patient's self-awareness about his/her own health status and the impact on family's daily life and social activities. A previous study revealed poor QOL of family caregivers of patients with cancers \[[@CR18]\]. Strain imposed by cancer associated pain and discomfort, impaired capacity for work, and the dependence on drugs and adjuvant therapy can affect the physical condition of family caregivers, and render them vulnerable to cognitive dysfunction and sleep disorders. The major causes that impair post-treatment social life of patients with breast cancer include physical changes (such as removal of mammary gland), pain, and psychological factors such as depression, irritability and anxiety \[[@CR19]--[@CR21]\]. With passage of time after completion of radiotherapy, patients tend to gradually accept the reality, which helps improve their social adaptability \[[@CR22]--[@CR24]\].

Breast, arm, and shoulder pain are commonly experienced by breast cancer patients after treatment \[[@CR25], [@CR26]\]; these were shown to significantly impair the long-term QoL of these patients \[[@CR27]\]. These symptoms may be attributable to tumor metastasis, anti-cancer therapy or to social-psychological factors. Previous studies have identified age, axillary lymph node dissection, and postoperative RT as significant risk factors \[[@CR25], [@CR28]\]. In the present study, only time elapsed since completion of RT was found to be associated with reduction in pain, after adjusting for age, educational level of patients, operation method, surgical staging and number of chemotherapy cycles; pain relief was especially noticeable after 2.5 to 4.5 years post-radiotherapy.

Scores pertaining to concerns about future state of health showed improvement from 2.5 to 3.5 years post-radiotherapy and a slight decline was also observed during the 3.5 to 4.5 year time window post-radiotherapy. The diagnosis and cure of breast cancer are both typically life-changing events which affect the patient's psychological health \[[@CR29]\]. At initial diagnosis, the patient typically experiences the psychological phenomenon of denial, anger, acceptance, depression, fear and survival, short-term lack of confidence and even fear for future health. Although the negative effects of disease on the patient exist, the positive effects of post-traumatic growth, however, helps augment patient's confidence and reduces their worries about future \[[@CR30]\]. More importantly, the confidence of patients is reinforced by the negative results of the annual cancer re-examination. Additionally, the recovery of functions in various aspects promotes the normal activities of daily living, which enable the patients to look forward to the future \[[@CR24]\].

The cross-sectional study design is the main limitation of this study. The design does not allow for causal inferences, but only describes the factors associated with self-reported QoL outcomes.

Conclusions {#Sec12}
===========

In this study cohort, time elapsed since completion of RT had significant impact on social function, pain symptoms, and concerns about future state of health of patients with breast cancer. These scales improved with passage of time after RT. Our results have profound guiding significance for QOL of patients with breast cancer after RT. Of note, breast cancer is a heterogeneous disease and these results are limited to the cross-sectional study. Further studies are needed to elucidate the possible impact of time elapsed since completion of RT on breast cancer patients.
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